» Articles » PMID: 10979064

Dying Well After Discontinuing the Life-support Treatment of Dialysis

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2000 Sep 9
PMID 10979064
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cessation of life-prolonging treatments precedes death in an increasing number of cases, but little attention has been accorded to the quality of dying.

Objective: To examine the quality of dying following dialysis termination.

Patients And Methods: A prospective cohort, observational study involved 6 dialysis clinics in the United States and 2 clinics in Canada, and 131 adult patients receiving maintenance dialysis who died after treatment cessation. Sixty percent (n = 79) underwent patient (n = 23) and/or family (n = 76) interviews and follow-up with caretakers. A quality of dying tool quantified duration, pain and suffering, and psychosocial factors.

Results: The sample was 59% female, the age was 70.0+/-1.2 years old, the duration of dialysis was 34.0+/-2.8 months, and death occurred 8.2+/-0.7 days after the last dialysis treatment. (Data are given as mean +/- SE.) Thirty-eight percent of the subjects who completed the protocol were judged to have had very good deaths, 47% had good deaths, and 15% had bad deaths. During the last day of life, 81% of the sample did not suffer, although 42% had some pain and an additional 5% had severe pain. According to the psychosocial domain of the quality of dying measure, patients who died at home or with hospice care had better deaths than those who died in a hospital or nursing home.

Conclusions: Most deaths following withdrawal of dialysis were good or very good. The influence of site of death and physician attitudes about decisions to stop life support deserves more research attention. Quality of dying tools can be used to establish benchmarks for the provision of terminal care.

Citing Articles

Quality assuring early dialysis care: evaluating rates of death and recovery within 90 days of first dialysis using the UK Renal Registry.

Hole B, Casula A, Caskey F Clin Kidney J. 2023; 15(8):1612-1621.

PMID: 37056423 PMC: 10087010. DOI: 10.1093/ckj/sfab238.


Association of Hospice Payer With Concurrent Receipt of Hospice and Dialysis Among US Veterans With End-stage Kidney Disease: A Retrospective Analysis of a National Cohort.

Wachterman M, Corneau E, OHare A, Keating N, Mor V JAMA Health Forum. 2022; 3(10):e223708.

PMID: 36269338 PMC: 9587478. DOI: 10.1001/jamahealthforum.2022.3708.


Parameters affecting prognosis after hemodialysis withdrawal: experience from a single center.

Yamaguchi K, Kitamura M, Takazono T, Yamamoto K, Hashiguchi J, Harada T Clin Exp Nephrol. 2022; 26(10):1022-1029.

PMID: 35666336 DOI: 10.1007/s10157-022-02242-9.


Exploration of Caregiver Experiences of Conservatively Managed End-Stage Kidney Disease to Inform Development of a Psychosocial Intervention: The ACORN Study Protocol.

Carswell C, Yaqoob M, Gilbert P, Kuan Y, Laurente G, McGuigan K Healthcare (Basel). 2021; 9(12).

PMID: 34946457 PMC: 8701309. DOI: 10.3390/healthcare9121731.


The Prevalence and Severity of Chronic Pain in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Davison S, Rathwell S, Ghosh S, George C, Pfister T, Dennett L Can J Kidney Health Dis. 2021; 8:2054358121993995.

PMID: 33680484 PMC: 7897838. DOI: 10.1177/2054358121993995.